2 recruiting, 1 active not recruiting, 1 not yet recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow ALN-CIDEB: new trials by email Literature Review of ALN-CIDEB trials Research Report on ALN-CIDEB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD) ALN-CIDEB, Placebo - Alcohol-Associated Liver Disease, ALD | Phase 2 | Not yet recruiting | Regeneron Pharmaceuticals | 120 | 2026-12-09 | 2026-11-12 |
| Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) ALN-CIDEB, Placebo - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 1500 | 2026-10-28 | 2026-11-05 |
| Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) ALN-CIDEB, Placebo - Metabolic Dysfunction-Associated Steatohepatitis, MASH | Phase 2 | Recruiting | Regeneron Pharmaceuticals | 360 | 2026-07-06 | 2026-11-09 |
| A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH) ALN-CIDEB, Placebo - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis | Phase 1 / Phase 2 | Active not recruiting | Regeneron Pharmaceuticals | 118 | 2025-04-28 | 2026-11-04 |
Non-alcoholic Fatty Liver Disease (4) · Fatty Liver (3) · Liver Cirrhosis (3) · Fibrosis (2) · Hepatitis (2) · Obesity (2) · Acute-On-Chronic Liver Failure (1) · Alcoholism (1) · End Stage Liver Disease (1) · Fatty Liver, Alcoholic (1) · Hepatitis, Alcoholic (1) · Hypertension, Portal (1) · Insulin Resistance (1) · Liver Cirrhosis, Alcoholic (1) · Liver Diseases, Alcoholic (1)
United States (3) · United Kingdom (2) · Puerto Rico (1)